Literature DB >> 17952897

Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee.

Raif S Geha1, Luigi D Notarangelo, Jean-Laurent Casanova, Helen Chapel, Mary Ellen Conley, Alain Fischer, Lennart Hammarström, Shigeaki Nonoyama, Hans D Ochs, Jennifer M Puck, Chaim Roifman, Reinhard Seger, Josiah Wedgwood.   

Abstract

Primary immunodeficiency diseases (PIDs) are a genetically heterogeneous group of disorders that affect distinct components of the innate and adaptive immune system, such as neutrophils, macrophages, dendritic cells, complement proteins, natural killer cells, and T and B lymphocytes. The study of these diseases has provided essential insights into the functioning of the immune system. More than 120 distinct genes have been identified, whose abnormalities account for more than 150 different forms of PID. The complexity of the genetic,immunologic, and clinical features of PID has prompted the need for their classification, with the ultimate goal of facilitating diagnosis and treatment. To serve this goal, an international committee of experts has met every 2 years since 1970. In its last meeting in Jackson Hole, Wyo, after 3 days of intense scientific presentations and discussions, the committee has updated the classification of PID, as reported in this article.

Entities:  

Mesh:

Year:  2007        PMID: 17952897      PMCID: PMC2601718          DOI: 10.1016/j.jaci.2007.08.053

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  20 in total

1.  Lymphopenic mice reconstituted with limited repertoire T cells develop severe, multiorgan, Th2-associated inflammatory disease.

Authors:  Joshua D Milner; Jerrold M Ward; Andrea Keane-Myers; William E Paul
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-03       Impact factor: 11.205

2.  The induction of Bim expression in human T-cell blasts is dependent on nonapoptotic Fas/CD95 signaling.

Authors:  Alberto Bosque; Juan Ignacio Aguiló; M Angeles Alava; Estela Paz-Artal; Javier Naval; Luis M Allende; Alberto Anel
Journal:  Blood       Date:  2006-10-24       Impact factor: 22.113

3.  A novel human primary immunodeficiency syndrome caused by deficiency of the endosomal adaptor protein p14.

Authors:  Georg Bohn; Anna Allroth; Gudrun Brandes; Jens Thiel; Erik Glocker; Alejandro A Schäffer; Chozhavendan Rathinam; Nicole Taub; David Teis; Cornelia Zeidler; Ricardo A Dewey; Robert Geffers; Jan Buer; Lukas A Huber; Karl Welte; Bodo Grimbacher; Christoph Klein
Journal:  Nat Med       Date:  2006-12-31       Impact factor: 53.440

4.  HAX1 deficiency causes autosomal recessive severe congenital neutropenia (Kostmann disease).

Authors:  Christoph Klein; Magda Grudzien; Giridharan Appaswamy; Manuela Germeshausen; Inga Sandrock; Alejandro A Schäffer; Chozhavendan Rathinam; Kaan Boztug; Beate Schwinzer; Nima Rezaei; Georg Bohn; Malin Melin; Göran Carlsson; Bengt Fadeel; Niklas Dahl; Jan Palmblad; Jan-Inge Henter; Cornelia Zeidler; Bodo Grimbacher; Karl Welte
Journal:  Nat Genet       Date:  2006-12-24       Impact factor: 38.330

5.  Secretory cytotoxic granule maturation and exocytosis require the effector protein hMunc13-4.

Authors:  Mickaël M Ménager; Gaël Ménasché; Maryse Romao; Perrine Knapnougel; Chen-Hsuan Ho; Mériem Garfa; Graça Raposo; Jérôme Feldmann; Alain Fischer; Geneviève de Saint Basile
Journal:  Nat Immunol       Date:  2007-01-21       Impact factor: 25.606

6.  Dominant-negative effect of the heterozygous C104R TACI mutation in common variable immunodeficiency (CVID).

Authors:  Lilit Garibyan; Adrian A Lobito; Richard M Siegel; Matthew E Call; Kai W Wucherpfennig; Raif S Geha
Journal:  J Clin Invest       Date:  2007-05-10       Impact factor: 14.808

7.  Defective DNA repair and increased genomic instability in Cernunnos-XLF-deficient murine ES cells.

Authors:  Shan Zha; Frederick W Alt; Hwei-Ling Cheng; James W Brush; Gang Li
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-07       Impact factor: 11.205

8.  A hypomorphic R229Q Rag2 mouse mutant recapitulates human Omenn syndrome.

Authors:  Veronica Marrella; Pietro Luigi Poliani; Anna Casati; Francesca Rucci; Laura Frascoli; Marie-Lise Gougeon; Brigitte Lemercier; Marita Bosticardo; Maria Ravanini; Manuela Battaglia; Maria Grazia Roncarolo; Marina Cavazzana-Calvo; Fabio Facchetti; Luigi D Notarangelo; Paolo Vezzoni; Fabio Grassi; Anna Villa
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

9.  Deletion of complement factor H-related genes CFHR1 and CFHR3 is associated with atypical hemolytic uremic syndrome.

Authors:  Peter F Zipfel; Matthew Edey; Stefan Heinen; Mihály Józsi; Heiko Richter; Joachim Misselwitz; Bernd Hoppe; Danny Routledge; Lisa Strain; Anne E Hughes; Judith A Goodship; Christoph Licht; Timothy H J Goodship; Christine Skerka
Journal:  PLoS Genet       Date:  2007-02-01       Impact factor: 5.917

10.  A LAD-III syndrome is associated with defective expression of the Rap-1 activator CalDAG-GEFI in lymphocytes, neutrophils, and platelets.

Authors:  Ronit Pasvolsky; Sara W Feigelson; Sara Sebnem Kilic; Amos J Simon; Guy Tal-Lapidot; Valentin Grabovsky; Jill R Crittenden; Ninette Amariglio; Michal Safran; Ann M Graybiel; Gideon Rechavi; Shifra Ben-Dor; Amos Etzioni; Ronen Alon
Journal:  J Exp Med       Date:  2007-06-18       Impact factor: 14.307

View more
  120 in total

1.  Implementing routine testing for severe combined immunodeficiency within Wisconsin's newborn screening program.

Authors:  Mei Wang Baker; Ronald H Laessig; Murray L Katcher; John M Routes; William J Grossman; James Verbsky; Daniel F Kurtycz; Charles D Brokopp
Journal:  Public Health Rep       Date:  2010 May-Jun       Impact factor: 2.792

2.  Nationwide survey of patients with primary immunodeficiency diseases in Japan.

Authors:  Masataka Ishimura; Hidetoshi Takada; Takehiko Doi; Kousuke Imai; Yoji Sasahara; Hirokazu Kanegane; Ryuta Nishikomori; Tomohiro Morio; Toshio Heike; Masao Kobayashi; Tadashi Ariga; Shigeru Tsuchiya; Shigeaki Nonoyama; Toshio Miyawaki; Toshiro Hara
Journal:  J Clin Immunol       Date:  2011-09-29       Impact factor: 8.317

3.  Validity of Primary Immunodeficiency Disease Diagnoses in United States Medicaid Data.

Authors:  Hillary Hernandez-Trujillo; Jordan S Orange; Jason A Roy; Yanli Wang; Craig N Newcomb; Qing Liu; Sean Hennessy; Vincent Lo Re
Journal:  J Clin Immunol       Date:  2015-08-14       Impact factor: 8.317

4.  The European internet-based patient and research database for primary immunodeficiencies: update 2011.

Authors:  B Gathmann; N Binder; S Ehl; G Kindle
Journal:  Clin Exp Immunol       Date:  2012-03       Impact factor: 4.330

5.  [Assessment of immunoglobulins in a long-term non-interventional study (SIGNS Study). Rationale, design, and methods].

Authors:  Wilhelm Kirch; Ralf Gold; Manfred Hensel; Maria Fasshauer; David Pittrow; Dörte Huscher; Marcel Reiser; Martin Stangel; Ulrich Baumann; Michael Borte
Journal:  Med Klin (Munich)       Date:  2010-09-28

Review 6.  Pneumococcal vaccine and patients with pulmonary diseases.

Authors:  Mehdi Mirsaeidi; Golnaz Ebrahimi; Mary Beth Allen; Stefano Aliberti
Journal:  Am J Med       Date:  2014-05-20       Impact factor: 4.965

7.  An immune globulin intravenous (human), 10% liquid privigen: for the treatment of primary immunodeficiency diseases.

Authors: 
Journal:  P T       Date:  2009-06

8.  Proinflammatory cytokine gene single nucleotide polymorphisms in common variable immunodeficiency.

Authors:  N Rezaei; A A Amirzargar; Y Shakiba; M Mahmoudi; B Moradi; A Aghamohammadi
Journal:  Clin Exp Immunol       Date:  2009-01       Impact factor: 4.330

9.  ORAI1 deficiency and lack of store-operated Ca2+ entry cause immunodeficiency, myopathy, and ectodermal dysplasia.

Authors:  Christie-Ann McCarl; Capucine Picard; Sara Khalil; Takumi Kawasaki; Jens Röther; Alexander Papolos; Jeffery Kutok; Claire Hivroz; Francoise Ledeist; Katrin Plogmann; Stephan Ehl; Gundula Notheis; Michael H Albert; Bernd H Belohradsky; Janbernd Kirschner; Anjana Rao; Alain Fischer; Stefan Feske
Journal:  J Allergy Clin Immunol       Date:  2009-12       Impact factor: 10.793

10.  Longitudinal analysis of immune function in the first 3 years of life in thymectomized neonates during cardiac surgery.

Authors:  E Mancebo; J Clemente; J Sanchez; J Ruiz-Contreras; P De Pablos; S Cortezon; E Romo; E Paz-Artal; L M Allende
Journal:  Clin Exp Immunol       Date:  2008-09-22       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.